echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > New technology for the treatment of fatal hernias in infants

    New technology for the treatment of fatal hernias in infants

    • Last Update: 2022-10-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
          

       

    Yi Hong

    A bioengineering researcher at the University of Texas at Arlington is leading a team to develop a biodegradable elastic patch as a new treatment
    for congenital diaphragmatic hernia (CDH).

    One in three newborns with this devastating disease dies
    .
    In the United States, five children are born with this birth defect
    every day.

    Professor Yi Hong of the Department of Bioengineering is teaming up with Aijun Wang and Diana L.
    Farmer, PhDs, of the University of California, Davis, and Jun Liao, associate professor of bioengineering at UT Arlington University, to compete for a $441,000 grant
    from the National Institutes of Health.

    "We're building something
    that allows kids to give, get, and grow with them," Hong said.
    CDH is a serious birth defect characterized by incomplete
    diaphragmatic development.

    Hong said that DHE causes the stomach and intestines to enter the chest, which compresses the lungs and impairs development
    .
    Surgery can sometimes repair defects; Otherwise, prosthetic patches must be used as bridges
    .
    These patches are usually made from synthetic, less biologically active materials such as Gore-Tex
    .

    "When the surgery is done, the plaques don't grow
    with the child.
    " "Also, children often get hernias again
    .
    Therefore, developing a biodegradable, more natural solution is crucial
    for the survival of these children.

    Michael Cho, professor and chair of UTA's Department of Bioengineering, said it could be a life-saving study
    .

    "Dr.
    Hong's research can help a lot of patients," Zhao said
    .
    "Taking research from our lab and using it in the medical field with partners makes UTA's research so personalized and so important
    to the university's representative.
    " It also represents the department's goal
    of driving translational and transformative research.

     

     


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.